Vaccines (Nov 2022)

A Reflection of Metabolic Syndrome through the Window of COVID-19

  • Liam Pock Ho,
  • Chuen Wen Tan,
  • Heng Joo Ng,
  • Wai Mun Jason Chay,
  • Jing Yuan Tan,
  • Su Yen Goh

DOI
https://doi.org/10.3390/vaccines10111966
Journal volume & issue
Vol. 10, no. 11
p. 1966

Abstract

Read online

COVID-19 and metabolic syndrome, though seemingly different disorders, appear to share certain common pathogenic components, especially in the development of COVID-19-associated diabetes mellitus. The similarities include impairment in immunoendothelial, gastrointestinal, pancreatic, adipose and mitochondrial functions, with several critical micronutrients undergirding the intricate interactions among these dysfunctions. This discussion aims to highlight the parallels between COVID-19 and metabolic syndrome and to propose the possibility of SARS-CoV-2 being a prototype of an acquired etiological agent which can eventually lead to the development of classical metabolic syndrome. Based on the proposed model, the discussion will include the implication for early management of COVID-19 and metabolic syndrome.

Keywords